newsfilter
← Latest News
GlobeNewswire·

Longeveron to Participate in the 149th Annual National Investment Banking Association Conference

MIAMI, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN, NASDAQ:LGVNR) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic